MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,297 | -38.8% | 79,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $38,054 | -23.5% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $49,738 | +34.0% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $37,130 | -61.7% | 79,000 | -32.8% | 0.00% | -50.0% |
| Q3 2022 | $97,000 | -26.5% | 117,500 | +4.0% | 0.00% | 0.0% |
| Q2 2022 | $132,000 | +17.9% | 113,000 | +28.4% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | -21.7% | 88,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $143,000 | -44.6% | 88,000 | -5.4% | 0.00% | -50.0% |
| Q3 2021 | $258,000 | -12.2% | 93,000 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $294,000 | -22.2% | 97,700 | +5.5% | 0.00% | -33.3% |
| Q1 2021 | $378,000 | -12.7% | 92,600 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $433,000 | +61.0% | 92,600 | +42.7% | 0.01% | +40.0% |
| Q3 2020 | $269,000 | +35.2% | 64,900 | +18.2% | 0.01% | +25.0% |
| Q2 2020 | $199,000 | – | 54,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 350,000 | $1,054,000 | 0.54% |
| AIGH Capital Management LLC | 915,000 | $2,768,000 | 0.50% |
| AWM Investment Company, Inc. | 1,000,000 | $3,017,000 | 0.30% |
| Board of Trustees of The Leland Stanford Junior University | 962,932 | $2,898,000 | 0.27% |
| Worth Venture Partners, LLC | 215,030 | $647,000 | 0.24% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 110,515 | $333,000 | 0.15% |
| INTACT INVESTMENT MANAGEMENT INC. | 385,600 | $1,427,000 | 0.04% |
| Verition Fund Management LLC | 539,051 | $1,623,000 | 0.02% |
| Patriot Financial Group Insurance Agency, LLC | 22,900 | $69,000 | 0.01% |
| Maven Securities LTD | 79,118 | $234,000 | 0.01% |